Association of histologic variants in FSGS clinical trial with presenting features and outcomes
about
FSGS: Diagnosis and Diagnostic Work-UpPathology of Podocytopathies Causing Nephrotic Syndrome in ChildrenThe Impact of Histologic Variants on FSGS OutcomesPathogenesis of Focal Segmental GlomerulosclerosisCitral is renoprotective for focal segmental glomerulosclerosis by inhibiting oxidative stress and apoptosis and activating Nrf2 pathway in miceIdiopathic collapsing focal segmental glomerulosclerosis in an 81-year-old Japanese woman: a case report and review of the literature.Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literatureUrinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosisSerum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients.Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialCollapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigationResurgence of membranous nephropathy in African Americans in inner city Chicago.A patient with nephrotic-range proteinuria and focal global glomerulosclerosis.Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury.Causes and pathogenesis of focal segmental glomerulosclerosis.Interventions for idiopathic steroid-resistant nephrotic syndrome in children.Steroid-resistant nephrotic syndrome: a persistent challenge for pediatric nephrology.Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.Incidences of membranous nephropathy versus focal segmental glomerulosclerosis: increase in the former or decline in the latter?A Multicenter Cohort Study of Histologic Findings and Long-Term Outcomes of Kidney Disease in Women Who Have Been Pregnant.The evolution of morphological variants of focal segmental glomerulosclerosis: a repeat biopsy-based observation.Reducing mTOR augments parietal epithelial cell density in a model of acute podocyte depletion and in aged kidneys.Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysisDetection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease.Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.A Clinicopathologic Study of Children with Idiopathic Focal Segmental Glomerulosclerosis.Tip variant of focal segmental glomerulosclerosis: is it truly a benign variant?
P2860
Q26744558-44B48565-E427-4204-8AA7-50903303757CQ26749359-19263A92-BC9D-4A3A-8170-D4DAB0562757Q27011243-0A9D43B0-376B-4568-8470-87E8995D6705Q28067299-07DAEED0-174D-49BA-84D1-6DCD62CAAF7BQ28533529-C43DA8E0-2819-4860-9E6E-3CC10F3F32A2Q33628328-9DCA064C-D9EC-410B-90CD-1DC720A8A91AQ33735329-604DD226-4C48-4118-B35B-1CC31AC6F6C0Q33783271-656921D8-E513-4689-B659-57779D19B926Q33826145-7C09A419-BCB7-402D-A42B-4428BFE47504Q34503209-68042B4F-826D-4A13-8A92-C24C8BB09237Q35658566-93D22B7B-E10D-4D7A-8B47-DF0697021D68Q36124605-0ED2C20B-1837-47EB-8DA4-F55A31FA9F4BQ36982075-FBAC5248-2938-4DA1-896B-95A1CD9FFFBDQ37280842-9B93626F-EAD1-485C-BA3C-2FFB49D3E738Q37476603-520F340E-956A-434C-BB6D-774DBBF31B34Q38275115-E0648C8C-DCAD-45FA-AE03-7F1AC1E489FCQ38801673-2F949008-247F-4B8F-B174-AB312C547BE3Q38991259-E44D9801-3FD8-4947-890D-3656D91455BDQ39573370-6856F36B-7057-4296-8F19-80847131E0EFQ39689329-83A1AE00-D99B-4254-8869-975C18CB013EQ40430668-1896E68E-7C78-4321-A7CB-824881569886Q40752049-7ACF0DF3-7C55-41BF-B77B-566516400F50Q42356978-EE68649C-C64F-460B-B066-F190033F4086Q42700702-EDD1FFD2-A657-43E4-A810-C0D66D58088BQ47110410-F08DAD22-C1C4-4864-BD98-58A7874E94CDQ47555950-C9F14DC7-76A3-49F6-AD91-07614D49E06AQ53127761-7FAE07C9-4C3C-4B2B-8917-098487F1D664Q53595522-F8744111-3F6B-480F-B295-4A0C110180B0
P2860
Association of histologic variants in FSGS clinical trial with presenting features and outcomes
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Association of histologic vari ...... esenting features and outcomes
@ast
Association of histologic vari ...... esenting features and outcomes
@en
type
label
Association of histologic vari ...... esenting features and outcomes
@ast
Association of histologic vari ...... esenting features and outcomes
@en
prefLabel
Association of histologic vari ...... esenting features and outcomes
@ast
Association of histologic vari ...... esenting features and outcomes
@en
P2093
P2860
P356
P1476
Association of histologic vari ...... esenting features and outcomes
@en
P2093
Aaron L Friedman
Agnes B Fogo
Arthur H Cohen
Charles E Alpers
Cynthia C Nast
Daniel A Savino
David B Thomas
Debbie S Gipson
Frederick J Kaskel
J Charles Jennette
P2860
P304
P356
10.2215/CJN.06100612
P577
2012-12-06T00:00:00Z